A reverse transcription-nested PCR assay for HHV-6 mRNA early transcript detection after transplantation

被引:17
|
作者
Pradeau, Karine
Bordessoule, Dominique
Szelag, Jean-Christophe
Rolle, Florence
Ferrat, Pierre
Le Meur, Yann
Turlure, Pascal
Denis, Franqois
Ranger-Rogez, Sylvie [1 ]
机构
[1] CHU Dupuytren, Lab Virol, Limoges, France
[2] CHU Dupuytren, Serv Hematol Clin & Therapie Cellulaire, Limoges, France
[3] CHU Dupuytren, Serv Nephrol, Limoges, France
[4] CHU Dupuytren, Serv Chirurg Thorac & Vasc, Limoges, France
[5] Fac Pharm, Lab Microbiol, F-87025 Limoges, France
关键词
HHV-6; reactivation; U79/80; gene; mRNA detection; RT-PCR; transplant recipients;
D O I
10.1016/j.jviromet.2005.11.015
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Monitoring of human herpesvirus-6 (HHV-6) reactivation is important, especially in immunocompromised patients such as transplant recipients. Reverse transcription PCR (RT-PCR) is a useful method to distinguish between latent and active infection. Here, a RT-nested PCR coupled with a colorimetric plate hybridization assay was established to detect HHV-6 types A and B U79/80 mRNAs. After confirming the reliability of the assay on HHV-6 cultures, it was applied to the detection of HHV-6 reactivation after renal (27 patients), bone marrow (14 patients) or heart (7 patients) transplantation. A total of 206 blood samples were tested from renal (137), bone marrow (58) and heart (11) transplant recipients. U79/80 mRNAs were found in 32 samples that were considered as indicative of HHV-6 reactivation: 15, 13 and 5 from kidney, bone marrow and heart transplant recipients, respectively. Finally, U79/80 mRNA detection was correlated with clinical manifestations including leucopenia, skin rash, graft rejection or dysfunction and diarrhoea. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 34 条
  • [31] Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells
    Schamhart, D
    Swinnen, J
    Kurth, KH
    Westerhof, A
    Kusters, R
    Borchers, H
    Sternberg, C
    CLINICAL CHEMISTRY, 2003, 49 (09) : 1458 - 1466
  • [32] HPV16-E6 mRNA is superior to Cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR
    Haefner, Norman
    Gajda, Mieczyslaw
    Altgassen, Christopher
    Hertel, Hermann
    Greinke, Christiane
    Hillemanns, Peter
    Schneider, Achim
    Duerst, Matthias
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (09) : 1842 - 1846
  • [33] Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer
    Ignatiadis, Michail
    Kallergi, Galatea
    Ntoulia, Maria
    Perraki, Maria
    Apostolaki, Stella
    Kafousi, Maria
    Chlouverakis, Grigorios
    Stathopoulos, Efstathios
    Lianidou, Evi
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2593 - 2600
  • [34] Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer
    Chen, Yan
    Zou, Tian Ning
    Wu, Zhi Ping
    Zhou, Yong Chun
    Gu, Yu Lan
    Liu, Xin
    Jin, Cong Guo
    Wang, Xi Cai
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2010, 25 (02): : 59 - 68